The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A randomized phase II study comparing mFOLFOX-6 combined with axitinib or bevacizumab or both in patients with metastatic colorectal cancer (mCRC).
Jeffrey R. Infante
Disclosure not yet available
Allen Lee Cohn
Disclosure not yet available
Tony R Reid
Disclosure not yet available
William Jeffery Edenfield
Disclosure not yet available
Terrence Cescon
Disclosure not yet available
John Turner Hamm
Disclosure not yet available
Jamal Christo Tarazi
Disclosure not yet available
Sinil Kim
Disclosure not yet available
Brad Rosbrook
Disclosure not yet available
Thomas H. Cartwright
Disclosure not yet available